⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4681387 | 0.86 | — | — | |
| SCHEMBL1098260 | 0.86 | — | — | |
| SCHEMBL357186 | 0.84 | — | — | |
| SCHEMBL4449152 | 0.84 | KMT2A (0.42) | — | |
| SCHEMBL8861033 | 0.84 | SLC6A1 (0.41) | — | |
| SCHEMBL4680953 | 0.82 | SLC6A1 (0.39) | — | |
| SCHEMBL25076027 | 0.80 | — | — | |
| SCHEMBL197439 | 0.80 | — | — | |
| SCHEMBL11799788 | 0.79 | SLC6A1 (0.48) | — | |
| SCHEMBL198419 | 0.79 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 125 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-6846827-B1 | Pyrimidine derivatives | ASTRAZENECA AB (SE) | 2005-01-25 | — | — | US | claimed |
| EP-1226126-B1 | PYRIMIDINE DERIVATIVES | ASTRAZENECA AB (SE) | 2005-01-05 | — | — | EP | claimed |
| EP-1226126-A1 | PYRIMIDINE DERIVATIVES | AstraZeneca AB (SE) | 2002-07-31 | — | — | EP | claimed |
| WO-2001027089-A1 | PYRIMIDINE DERIVATIVES | ASTRAZENECA AB (SE) | 2001-04-19 | — | — | WO | claimed |
| EP-3468953-B1 | SUBSTITUTED PYRIDINES AS INHIBITORS OF DNMT1 | GLAXOSMITHKLINE IP DEV LTD (GB) | 2024-05-22 | — | — | EP | disclosed |
| CN-115279940-B | Aluminum precursor compound, method for producing the same, and method for forming aluminum-containing film using the same | UP化学株式会社 | 2024-04-09 | — | — | CN | disclosed |
| CN-116762203-A | Nonaqueous electrolyte for lithium secondary battery, lithium secondary battery precursor, lithium secondary battery, and method for producing lithium secondary battery | 三井化学株式会社 | 2023-09-15 | — | — | CN | disclosed |
| CN-115668571-A | Electrolyte solution, electrochemical device, lithium ion secondary battery, module, and compound | 大金工业株式会社 | 2023-01-31 | — | — | CN | disclosed |
| CN-115668569-A | Electrolyte solution, electrochemical device, lithium ion secondary battery, and assembly | 大金工业株式会社 | 2023-01-31 | — | — | CN | disclosed |
| US-20230019365-A1 | ALUMINUM PRECURSOR COMPOUND, PRODUCTION METHOD THEREFOR, AND ALUMINUM CONTAINING LAYER FORMING METHOD USING SAME | UP CHEMICAL CO., LTD. (KR) | 2023-01-19 | — | — | US | disclosed |
| CN-115279940-A | Aluminum precursor compound, method for preparing the same, and method for forming aluminum-containing film using the same | UP化学株式会社 | 2022-11-01 | — | — | CN | disclosed |
| CN-114957050-A | Lithium aminosulfonate | 大金工业株式会社 | 2022-08-30 | — | — | CN | disclosed |
| EP-1226126-A1 | PYRIMIDINE DERIVATIVES | AstraZeneca AB (SE) | 2002-07-31 | — | — | EP | disclosed |
| US-6265418-B1 | ANTICOAGULANTS | UBE INDUSTRIES, LTD. (JP) | 2001-07-24 | — | — | US | disclosed |
| WO-2001027089-A1 | PYRIMIDINE DERIVATIVES | ASTRAZENECA AB (SE) | 2001-04-19 | — | — | WO | disclosed |
| CN-1265661-A | N-acylamino acid amide compounds and intermediates for preparation thereof | UBE INDUSTRIES (JP) | 2000-09-06 | — | — | CN | disclosed |
| EP-1020467-A1 | N-ACYLAMINO ACID AMIDE COMPOUNDS AND INTERMEDIATES FOR PREPARATION THEREOF | UBE INDUSTRIES LIMITED (JP) | 2000-07-19 | — | — | EP | disclosed |
| US-5017724-A | Antihypoxic, CNS | OTSUKA PHARMACEUTICAL CO., LTD. (JP) | 1991-05-21 | — | — | US | disclosed |
| EP-0267024-B1 | HYDROFLUORENE DERIVATIVES | OTSUKA PHARMACEUTICAL CO., LTD. (JP) | 1991-05-02 | — | — | EP | disclosed |
| EP-0267024-A2 | Hydrofluorene derivatives | OTSUKA PHARMACEUTICAL CO., LTD. (JP) | 1988-05-11 | — | — | EP | disclosed |